Defendants' motion for attorneys' fees under Section 285 was granted. "It was obvious from very early on that plaintiffs had brought and were maintaining this lawsuit in a desperate effort to keep any competing product from hitting the shelves -- even if the competing product was not an infringing product. For choosing that bad faith business strategy, and for cluttering a busy court with work that should never have had to be done, [plaintiffs] should pay the full measure of the fees and expenses incurred by defendants in getting rid of [plaintiffs'] baseless lawsuit."
AstraZeneca AB et al. v. Dr. Reddy's Laboratories, Ltd. et al., 1-07-cv-06790 (NYSD March 30, 2010, Decision & Order) (McMahon, J.)